Summary The Traumatic Brain Injury Partnering 2007-2012 report provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/traumatic-brain-injury-partnering-2007-2012.html Trends in traumatic brain injury partnering deals Top traumatic brain injury deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Description The Traumatic Brain Injury Partnering 2007-2012 provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of traumatic brain injury partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors traumatic brain injury technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not. This data driven report contains over 40 links to online copies of actual traumatic brain injury deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of traumatic brain injury partnering trends. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in traumatic brain injury partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends. Chapter 3 provides an overview of the leading traumatic brain injury deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive directory of traumatic brain injury partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of traumatic brain injury technologies and products. Report scope Traumatic Brain Injury Partnering 2007-2012 is intended to provide the reader with an in-depth understanding and access to traumatic brain injury trends and structure of deals entered into by leading companies worldwide. This data driven report includes: Trends in traumatic brain injury dealmaking in the biopharma industry since 2007 Access to summary headline, upfront, milestone and royalty data The leading traumatic brain injury deals by value since 2007 In Traumatic Brain Injury Partnering 2007-2012, the available deals are listed by: Headline value Upfront payment value Royalty rate value Company A-Z Industry sector Stage of development at signing Deal component type Technology type Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Benefits Traumatic Brain Injury Partnering 2007-2012 provides the reader with the following key benefits: In-depth understanding of traumatic brain injury deal trends since 2007 Access to summary headline, upfront, milestone and royalty data Comprehensive access to over 40 actual traumatic brain injury deals entered into by the world’s biopharma companies since 2007 Insight into key deal terms included in contracts, where disclosed Understand the key deal terms companies have agreed in deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies Executive Summary Chapter 1 – Introduction Chapter 2 – Trends in traumatic brain injury partnering 2.1. Introduction 2.2. Traumatic brain injury partnering over the years 2.3. Bigpharma traumatic brain injury dealmaking activity 2.4. Traumatic brain injury partnering by deal type 2.5. Traumatic brain injury partnering industry sector 2.6. Traumatic brain injury partnering by stage of development 2.7. Traumatic brain injury partnering by technology type 2.8. Disclosed financial deal terms for traumatic brain injury partnering 2.8.1 Traumatic brain injury headline values 2.8.2 Traumatic brain injury upfront payments 2.8.3 Traumatic brain injury milestone payments 2.8.4 Traumatic brain injury royalty rates Chapter 3 – Leading traumatic brain injury deals 3.1. Introduction 3.2. Top traumatic brain injury deals by value 3.3. Top traumatic brain injury deals involving bigpharma Chapter 4 – Dealmaking directory 4.1. Introduction 4.2. Company A-Z 4.3. By deal type Asset purchase Bigpharma outlicensing Co-development Collaborative R&D Co-market Contract service Co-promotion CRADA Cross-licensing Development Distribution Equity purchase Evaluation Grant Joint venture Licensing Manufacturing Marketing Option Promotion Research Settlement Spin out Sub-license Supply Termination 4.4. By industry sector Academic Bigpharma Biotech Drug delivery Medical device Diagnostic Generic pharma Government Non-profit Pharmaceutical Research tools Services Specialty pharma 4.5. By stage of development Discovery Pre-clinical Phase I Phase II Phase III Registration Marketed 4.6. By technology type Analysis Animal models Assays Bioinformatics Biological compounds Biomarkers Biomaterials Cell culture Cell therapy Clinical testing Diagnostic - companion Devices Diagnostics Discovery tools DNA probes Drug delivery Enabling technology Epigenetics Equipment Facilities Gene therapy Genomics Imaging Industrial chemicals In vitro models Monoclonal antibodies Nanotechnology Oligonucleotide Peptides Personalised medicine Processes Proteomics Radio/Chemo-therapy Recombinant DNA Research services Research supplies RNA therapeutics Screening Small molecules Stem cells Vaccines For more information kindly visit : Traumatic Brain Injury Partnering 2007-2012 Or Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Fax: + 91 22 27812290 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: https://twitter.com/BharatBook Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512 http://financemarketreports.blogspot.com/
Related Articles -
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletter,
|